PD-L1 and IDO1 Are Expressed in Poorly Differentiated Thyroid Carcinoma

Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer

Julie R. Brahmer, Scott S. Tykodi, Laura Q.M. Chow et al. · New England Journal of Medicine · 2012 · 8K citations · Full text

Life Sciences, Immunology, Oncology +17

Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade

Dung T. Le, Jennifer N. Durham, Kellie N. Smith et al. · Science · 2017 · 6.6K citations

Life Sciences, Immunology, Oncology +17

Molecular and Genetic Properties of Tumors Associated with Local Immune Cytolytic Activity

Michael S. Rooney, Sachet A. Shukla, Catherine J. Wu et al. · Cell · 2015 · 4.1K citations · Full text

Medicine, Immunology, Oncology +17

The Vigorous Immune Microenvironment of Microsatellite Instable Colon Cancer Is Balanced by Multiple Counter-Inhibitory Checkpoints

Nicolás J. Llosa, Michael Cruise, Ada Tam et al. · Cancer Discovery · 2014 · 1.5K citations · Full text

Life Sciences, Cell Biology, Tumor Immunology +6

Genomic and transcriptomic hallmarks of poorly differentiated and anaplastic thyroid cancers

Iñigo Landa, Tihana Ibrahimpašić, Laura Boucai et al. · Journal of Clinical Investigation · 2016 · 1.3K citations · Full text

Life Sciences, Genetics, Oncology +17